AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems
Wang Y, Hoinka J, Liang Y, Adamus T, Swiderski P, Przytycka TM. Nucleic Acids Res. 2018 Jul 9. PubMed
In vitro selection of an XNA aptamer capable of small-molecule recognition
Rangel AE, Chen Z, Ayele TM, Heemstra JM. Nucleic Acids Res. 2018 Jul 31. PubMed
Aptamers: Uptake mechanisms and intracellular applications
Yoon S, Rossi JJ. Adv Drug Deliv Rev. 2018 Jul 6. PubMed
Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective
Vandghanooni S, Eskandani M, Barar J, Omidi Y. J Mol Med (Berl). 2018 Jul 28. PubMed
Creation of unnatural base pairs for genetic alphabet expansion toward synthetic xenobiology
Hamashima K, Kimoto M, Hirao I. Curr Opin Chem Biol. 2018 Jul 27;46:108-114. PubMed
Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass
Gunaratne R, Kumar S, Frederiksen JW, Stayrook S, Lohrmann JL, Perry K, Bompiani KM, Chabata CV, Thalji NK, Ho MD, Arepally G, Camire RM, Krishnaswamy S, Sullenger BA. Nat Biotechnol. 2018 Jun 4. PubMed
Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines
Porciani D, Cardwell LN, Tawiah KD, Alam KK, Lange MJ, Daniels MA, Burke DH. Nat Commun. 2018 Jun 11;9(1):2283. PubMed
Chloroquine in combination with aptamer modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin-shRNA co-delivery to overcome drugresistance in EGFR-mutated NSCLC
Lv T, Li Z, Xu L, Zhang Y, Chen H, Gao Y. Acta Biomater. 2018 Jun 27. pii: S1742-7061(18)30380-5. PubMed
Novel DNA Aptamers for Parkinson’s Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation
Zheng Y, Qu J, Xue F, Zheng Y, Yang B, Chang Y, Yang H, Zhang J. Mol Ther Nucleic Acids. 2018 Jun 1;11:228-242. PubMed
SRB-2: a promiscuous rainbow aptamer for live-cell RNA imaging
Sunbul M, Jäschke A. Nucleic Acids Res. 2018 Jun 21. PubMed
